pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3194 |
Genomic Coordinates | chr20: 51452905 - 51452977 |
Description | Homo sapiens miR-3194 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||
---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3194-5p | ||||||
Sequence | 10| GGCCAGCCACCAGGAGGGCUG |30 | ||||||
Evidence | Experimental | ||||||
Experiments | Illumina | ||||||
SNPs in miRNA |
|
||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | KCNIP2 | ||||||||||||||||||||
Synonyms | KCHIP2 | ||||||||||||||||||||
Description | potassium voltage-gated channel interacting protein 2 | ||||||||||||||||||||
Transcript | NM_014591 | ||||||||||||||||||||
Other Transcripts | NM_173191 , NM_173192 , NM_173193 , NM_173194 , NM_173195 , NM_173197 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on KCNIP2 | |||||||||||||||||||||
3'UTR of KCNIP2 (miRNA target sites are highlighted) |
>KCNIP2|NM_014591|3'UTR 1 CCCCCAGGAGAGGGGGTCAGTGTTTCCTGGGGGGACCATGCTCTAACCCTAGTCCAGGCGGACCTCACCCTTCTCTTCCC 81 AGGTCTATCCTCATCCTACGCCTCCCTGGGGGCTGGAGGGATCCAAGAGCTTGGGGATTCAGTAGTCCAGATCTCTGGAG 161 CTGAAGGGGCCAGAGAGTGGGCAGAGTGCATCTCGGGGGGTGTTCCCAACTCCCACCAGCTCTCACCCCCTTCCTGCCTG 241 ACACCCAGTGTTGAGAGTGCCCCTCCTGTAGGAATTGAGCGGTTCCCCACCTCCTACCCCTACTCTAGAAACACACTAGA 321 CAGATGTCTCCTGCTATGGTGCTTCCCCCATCCCTGACCTCATAAACATTTCCCCTAAGACTCCCCTCTCAGAGAGAATG 401 CTCCATTCTTGGCACTGGCTGGCTTCTCAGACCAGCCATTGAGAGCCCTGTGGGAGGGGGACAAGAATGTATAGGGAGAA 481 ATCTTGGGCCTGAGTCAATGGATAGGTCCTAGGAGGTGGCTGGGGTTGAGAATAGAAGGGCCTGGACAGATTATGATTGC 561 TCAGGCATACCAGGTTATAGCTCCAAGTTCCACAGGTCTGCTACCACAGGCCATCAAAATATAAGTTTCCAGGCTTTGCA 641 GAAGACCTTGTCTCCTTAGAAATGCCCCAGAAATTTTCCACACCCTCCTCGGTATCCATGGAGAGCCTGGGGCCAGATAT 721 CTGGCTCATCTCTGGCATTGCTTCCTCTCCTTCCTTCCTGCATGTGTTGGTGGTGGTTGTGGTGGGGGAATGTGGATGGG 801 GGATGTCCTGGCTGATGCCTGCCAAAATTTCATCCCACCCTCCTTGCTTATCGTCCCTGTTTTGAGGGCTATGACTTGAG 881 TTTTTGTTTCCCATGTTCTCTATAGACTTGGGACCTTCCTGAACTTGGGGCCTATCACTCCCCACAGTGGATGCCTTAGA 961 AGGGAGAGGGAAGGAGGGAGGCAGGCATAGCATCTGAACCCAGTGTGGGGGCATTCACTAGAATCTTCAATCAACCTGGG 1041 CTCTCCCCACCCCACCCCAGATAACCTCCTCAGTTCCCTAGGGTCTCTTCTTGCTTGACTCAATCTACCCAGAGATGCCC 1121 CTTAGCACACCTAGAGGGCAGGGACCATAGGACCCAGGTTCCAACCCCATTGTCAGCACCCCAGCCATGCGGCCACCCCT 1201 TAGCACACCTGCTCGTCCCATTTAGCTTACCCTCCCAGTTGGCCAGAATCTGAGGGGAGAGCCCCCAGAGAGCCCCCTTC 1281 CCCATCAGAAGACTGTTGACTGCTTTGCATTTTGGGCTCTTCTATATATTTTGTAAAGTAAGAAATATACCAGATCTAAT 1361 AAAACACAATGGCTATGCAAAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | LCL-BAC | ||||||
Disease | MIMAT0015078 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1020023. RNA binding protein: AGO2. Condition:EBV B95-8-infected
... - Skalsky RL; Corcoran DL; Gottwein E; Frank et al., 2012, PLoS pathogens. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Skalsky RL; Corcoran DL; Gottwein E; Frank et al. - PLoS pathogens, 2012
Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus linked to a number of B cell cancers and lymphoproliferative disorders. During latent infection, EBV expresses 25 viral pre-microRNAs (miRNAs) and induces the expression of specific host miRNAs, such as miR-155 and miR-21, which potentially play a role in viral oncogenesis. To date, only a limited number of EBV miRNA targets have been identified; thus, the role of EBV miRNAs in viral pathogenesis and/or lymphomagenesis is not well defined. Here, we used photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) combined with deep sequencing and computational analysis to comprehensively examine the viral and cellular miRNA targetome in EBV strain B95-8-infected lymphoblastoid cell lines (LCLs). We identified 7,827 miRNA-interaction sites in 3,492 cellular 3'UTRs. 531 of these sites contained seed matches to viral miRNAs. 24 PAR-CLIP-identified miRNA:3'UTR interactions were confirmed by reporter assays. Our results reveal that EBV miRNAs predominantly target cellular transcripts during latent infection, thereby manipulating the host environment. Furthermore, targets of EBV miRNAs are involved in multiple cellular processes that are directly relevant to viral infection, including innate immunity, cell survival, and cell proliferation. Finally, we present evidence that myc-regulated host miRNAs from the miR-17/92 cluster can regulate latent viral gene expression. This comprehensive survey of the miRNA targetome in EBV-infected B cells represents a key step towards defining the functions of EBV-encoded miRNAs, and potentially, identifying novel therapeutic targets for EBV-associated malignancies.
LinkOut: [PMID: 22291592]
|
CLIP-seq Support 1 for dataset GSM1020023 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | LCL-BAC / EBV B95-8-infected, 4-thiouridine, RNase T1 |
Location of target site | ENST00000348850.5 | 3UTR | UUGGCACUGGCUGGCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22291592 / GSE41437 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
72 hsa-miR-3194-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT443250 | C9orf170 | chromosome 9 open reading frame 170 | 2 | 2 | ||||||||
MIRT443284 | ZC3H12A | zinc finger CCCH-type containing 12A | 2 | 2 | ||||||||
MIRT461518 | EMC7 | ER membrane protein complex subunit 7 | 2 | 2 | ||||||||
MIRT466738 | SYNJ2BP | synaptojanin 2 binding protein | 2 | 2 | ||||||||
MIRT467651 | SLC7A1 | solute carrier family 7 member 1 | 2 | 2 | ||||||||
MIRT472998 | MRPS23 | mitochondrial ribosomal protein S23 | 2 | 4 | ||||||||
MIRT477911 | DUSP2 | dual specificity phosphatase 2 | 2 | 2 | ||||||||
MIRT480853 | BLCAP | bladder cancer associated protein | 2 | 2 | ||||||||
MIRT482890 | IAH1 | isoamyl acetate-hydrolyzing esterase 1 homolog | 2 | 4 | ||||||||
MIRT487295 | SLC38A9 | solute carrier family 38 member 9 | 2 | 2 | ||||||||
MIRT488494 | SFMBT2 | Scm like with four mbt domains 2 | 2 | 4 | ||||||||
MIRT489060 | STARD3 | StAR related lipid transfer domain containing 3 | 2 | 2 | ||||||||
MIRT491209 | MLLT1 | MLLT1, super elongation complex subunit | 2 | 4 | ||||||||
MIRT491479 | APC2 | APC2, WNT signaling pathway regulator | 2 | 8 | ||||||||
MIRT492558 | PRX | periaxin | 2 | 6 | ||||||||
MIRT495499 | SLC39A2 | solute carrier family 39 member 2 | 2 | 2 | ||||||||
MIRT496578 | ZNF280D | zinc finger protein 280D | 2 | 2 | ||||||||
MIRT496840 | KCNIP2 | potassium voltage-gated channel interacting protein 2 | 2 | 2 | ||||||||
MIRT497840 | CHD1 | chromodomain helicase DNA binding protein 1 | 2 | 2 | ||||||||
MIRT499396 | PLCG2 | phospholipase C gamma 2 | 2 | 7 | ||||||||
MIRT503237 | C16orf74 | chromosome 16 open reading frame 74 | 2 | 4 | ||||||||
MIRT512345 | ZNF665 | zinc finger protein 665 | 2 | 4 | ||||||||
MIRT512527 | ATCAY | ATCAY, caytaxin | 2 | 4 | ||||||||
MIRT513160 | PPIB | peptidylprolyl isomerase B | 2 | 2 | ||||||||
MIRT514493 | STOML1 | stomatin like 1 | 2 | 2 | ||||||||
MIRT517164 | SLC28A1 | solute carrier family 28 member 1 | 2 | 2 | ||||||||
MIRT520463 | TRPV2 | transient receptor potential cation channel subfamily V member 2 | 2 | 2 | ||||||||
MIRT524151 | DIP2A | disco interacting protein 2 homolog A | 2 | 2 | ||||||||
MIRT530324 | TNFRSF10D | TNF receptor superfamily member 10d | 2 | 2 | ||||||||
MIRT533747 | TMEM184B | transmembrane protein 184B | 2 | 2 | ||||||||
MIRT534259 | SLC12A7 | solute carrier family 12 member 7 | 2 | 2 | ||||||||
MIRT561273 | ZDHHC18 | zinc finger DHHC-type containing 18 | 2 | 2 | ||||||||
MIRT569126 | TMC5 | transmembrane channel like 5 | 2 | 4 | ||||||||
MIRT569937 | RAB8A | RAB8A, member RAS oncogene family | 2 | 2 | ||||||||
MIRT570073 | VPS8 | VPS8, CORVET complex subunit | 2 | 2 | ||||||||
MIRT570636 | KLF13 | Kruppel like factor 13 | 2 | 2 | ||||||||
MIRT571026 | CENPP | centromere protein P | 2 | 2 | ||||||||
MIRT573838 | ZWINT | ZW10 interacting kinetochore protein | 2 | 2 | ||||||||
MIRT574899 | Plcg2 | phospholipase C, gamma 2 | 2 | 5 | ||||||||
MIRT576070 | Poteg | POTE ankyrin domain family, member G | 2 | 2 | ||||||||
MIRT576753 | Tmem127 | transmembrane protein 127 | 2 | 2 | ||||||||
MIRT611795 | WNT9A | Wnt family member 9A | 2 | 2 | ||||||||
MIRT616756 | SVOP | SV2 related protein | 2 | 2 | ||||||||
MIRT630965 | NGDN | neuroguidin | 2 | 2 | ||||||||
MIRT634555 | LYVE1 | lymphatic vessel endothelial hyaluronan receptor 1 | 2 | 2 | ||||||||
MIRT638646 | GK5 | glycerol kinase 5 (putative) | 2 | 2 | ||||||||
MIRT639903 | SRGAP2 | SLIT-ROBO Rho GTPase activating protein 2 | 2 | 2 | ||||||||
MIRT640529 | TET3 | tet methylcytosine dioxygenase 3 | 2 | 4 | ||||||||
MIRT644529 | TMEM134 | transmembrane protein 134 | 2 | 2 | ||||||||
MIRT644887 | C2orf50 | chromosome 2 open reading frame 50 | 2 | 2 | ||||||||
MIRT647729 | CXCR2 | C-X-C motif chemokine receptor 2 | 2 | 2 | ||||||||
MIRT648086 | FAM192A | family with sequence similarity 192 member A | 2 | 2 | ||||||||
MIRT650808 | PGRMC1 | progesterone receptor membrane component 1 | 2 | 2 | ||||||||
MIRT660505 | ARPC2 | actin related protein 2/3 complex subunit 2 | 2 | 2 | ||||||||
MIRT667193 | NODAL | nodal growth differentiation factor | 2 | 2 | ||||||||
MIRT685675 | PSMB7 | proteasome subunit beta 7 | 2 | 2 | ||||||||
MIRT692710 | MEAF6 | MYST/Esa1 associated factor 6 | 2 | 2 | ||||||||
MIRT693598 | SLC39A1 | solute carrier family 39 member 1 | 2 | 2 | ||||||||
MIRT698059 | TRIOBP | TRIO and F-actin binding protein | 2 | 2 | ||||||||
MIRT698292 | TMEM2 | transmembrane protein 2 | 2 | 2 | ||||||||
MIRT702353 | KLHL26 | kelch like family member 26 | 2 | 2 | ||||||||
MIRT708623 | NUDT18 | nudix hydrolase 18 | 2 | 2 | ||||||||
MIRT714289 | KBTBD11 | kelch repeat and BTB domain containing 11 | 2 | 2 | ||||||||
MIRT714577 | WDR41 | WD repeat domain 41 | 2 | 2 | ||||||||
MIRT716734 | APOL6 | apolipoprotein L6 | 2 | 2 | ||||||||
MIRT718781 | RAC3 | Rac family small GTPase 3 | 2 | 2 | ||||||||
MIRT720973 | ZBTB43 | zinc finger and BTB domain containing 43 | 2 | 2 | ||||||||
MIRT720986 | TOM1 | target of myb1 membrane trafficking protein | 2 | 2 | ||||||||
MIRT721391 | LDLRAD4 | low density lipoprotein receptor class A domain containing 4 | 2 | 2 | ||||||||
MIRT722905 | COA4 | cytochrome c oxidase assembly factor 4 homolog | 2 | 2 | ||||||||
MIRT723205 | ZNRF1 | zinc and ring finger 1 | 2 | 2 | ||||||||
MIRT725431 | HIVEP3 | human immunodeficiency virus type I enhancer binding protein 3 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|